文献速递青光眼

HORIZON与COMPASS试验中随机化前青光眼药物洗脱后的眼压变化

Intraocular Pressure Following Prerandomization Glaucoma Medication Washout in the HORIZON and COMPASS Trials.
PubMed 文献 · Am J Ophthalmol · 2020-04-11

该研究对两项前瞻性多中心随机临床试验的随机化前数据进行了二次分析,纳入1,400例原发性开角型青光眼患者(1,400眼),在协议规定的药物洗脱期前后行Goldmann压平眼压计测量。结果显示,停用降眼压药物后眼压升高呈剂量依赖性,且两个独立试验队列的洗脱后眼压变化相似。较厚的中央角膜厚度和既往选择性激光小梁成形术史可能预测对降眼压药物的反应减弱。

要点

  • 停用降眼压药物后眼压升高呈剂量依赖性,使用药物类别数越多升高越明显(P < .001)。
  • HORIZON与COMPASS两个独立队列的洗脱后眼压变化相似。
  • 较厚中央角膜厚度和既往SLT史可能与对降眼压药物反应减弱相关。

核心结论

  • 停用青光眼药物导致接受治疗的开角型青光眼患者出现剂量依赖性眼压升高。
  • 两个独立临床试验队列采用标准化方法估计真实世界药物有效性,洗脱后眼压升高程度相似。
  • 较厚CCT和SLT史可能预测对降眼压药物的反应减弱。

研究设计与样本

  • 两项前瞻性、多中心、随机临床试验随机化前数据的二次分析。
  • 共1,400例原发性开角型青光眼患者(1,400眼),其中HORIZON研究781眼、COMPASS研究619眼。
  • 患者使用0-4类局部降眼压药物,在协议规定的洗脱期前后行Goldmann压平眼压计测量。

主要发现

  • 使用0、1、2、3、4种药物的患者洗脱后眼压变化分别为0.2(2.8)、5.7(3.3)、6.9(3.7)、8.8(5.0)、9.5(4.1)mm Hg(P < .001,Kruskal-Wallis检验)。
  • HORIZON与COMPASS队列的洗脱后眼压变化相似。
  • 单药治疗患者中,各前列腺素类似物之间未检测到洗脱后眼压变化的差异。
  • 广义线性模型识别出与洗脱后眼压升高更大的相关因素:更多青光眼药物种类、更高未用药眼压、更薄CCT、无既往SLT史、男性。

临床怎么用

  • 在评估真实世界降眼压药物有效性时,应考虑药物洗脱导致的剂量依赖性眼压升高。
  • 对于中央角膜厚度较厚或有SLT史的患者,需注意其可能对降眼压药物反应减弱。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: To assess the effectiveness of topical ocular hypotensive medications in patients with open-angle glaucoma and to identify factors associated with postwashout intraocular pressure (IOP) elevation. DESIGN: Secondary analysis of prerandomization data from 2 prospective, multicenter, randomized clinical trials. METHODS: Fourteen hundred subjects (1,400 eyes, 781 from the HORIZON study of the Hydrus micro-stent and 619 from the COMPASS study of the Cypass micro-stent) with primary open-angle glaucoma who were using 0-4 classes of topical IOP-lowering medication underwent Goldmann applanation tonometry before and after a protocol-defined washout period. RESULTS: The mean (standard deviation) age was 70.7 (8.0) years and 55.6% were female. The change in IOP following washout for patients using 0 (n = 100), 1 (n = 705), 2 (n = 355), 3 (n = 214), or 4 (n = 26) medications was 0.2 (2.8), 5.7 (3.3), 6.9 (3.7), 8.8 (5.0), and 9.5 (4.1) mm Hg, respectively (P < .001, Kruskal-Wallis test). Postwashout IOP change was similar between the HORIZON and COMPASS cohorts. No difference in postwashout IOP change was detected among individual prostaglandin analogues in patients on monotherapy. A generalized linear model identified the following factors to be associated with greater IOP rise upon medication washout: greater number of glaucoma medications, higher unmedicated IOP, thinner central corneal thickness (CCT), lack of prior selective laser trabeculoplasty (SLT), and male sex. CONCLUSIONS: Cessation of glaucoma medications results in a dose-dependent IOP increase in treated open-angle glaucoma patients. Two independent clinical trial cohorts exhibit similar levels of IOP elevation upon washout, using standardized methodology to estimate real-world medication effectiveness. Thicker CCT and history of SLT may predict reduced response to IOP lowering medications.

来源:Am J Ophthalmol,查看原文。版权归原作者所有。

引用

  1. Johnson TV, Jampel HD. Intraocular Pressure Following Prerandomization Glaucoma Medication Washout in the HORIZON and COMPASS Trials. Am J Ophthalmol. 2020. PMID: 32289292. doi:10.1016/j.ajo.2020.04.008

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。